Skip to main content
KOREA PHARMA Co., Ltd. logo

KOREA PHARMA Co., Ltd. — Investor Relations & Filings

Ticker · 032300 ISIN · KR7032300006 KO Manufacturing
Open in API
Filings indexed 175 across all filing types
Latest filing 2023-08-18 Major Shareholding Noti…
Country KR South Korea
Listing KO 032300

About KOREA PHARMA Co., Ltd.

https://www.koreapharma.co.kr/eng/main/…

KOREA PHARMA Co., Ltd. is a pharmaceutical company established in 1974 that specializes in the development and production of prescription-based medicines. The company has a particular focus on drugs for the Central Nervous System (CNS). Its product portfolio covers a wide range of therapeutic areas, including hepatic, gastrointestinal, antimicrobial, and antihistamine drugs. The company also offers treatments such as amino acids, antibiotics, antidotes, and antiepileptics, aiming to improve and maintain public health through its specialized pharmaceutical products.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (Park Eun-hee and special related parties) in Korea Pharma. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-08-18 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Korea Pharma, covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial data, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean
투자판단관련주요경영사항(임상시험계획변경승인)(철 결핍성 빈혈 치료제KP-01의 제1상 임상시험계획 변경승인)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure filed by a Korean company (한국파마) regarding the approval of a clinical trial plan amendment (임상시험계획 변경승인). It follows the standard format for 'Major Management Matters' (주요경영사항) filings on the KRX (Korea Exchange) platform. Since it is a specific regulatory announcement regarding clinical trial status and does not fit into categories like financial reports, dividends, or M&A, it is classified as a general regulatory filing.
2023-07-19 Korean
투자판단관련주요경영사항(임상시험계획변경승인신청)(철 결핍성 빈혈 치료제KP-01의 제1상 임상시험계획 변경승인 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Major Management Matter' (투자판단 관련 주요경영사항) disclosure. It details an application for a change in a clinical trial plan (IND amendment) for a pharmaceutical product (KP-01). Since this is a specific regulatory announcement regarding company operations and clinical trial status, and it does not fit into the other specialized categories like financial reports or shareholder meetings, it falls under the 'Regulatory Filings' category.
2023-06-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including reasons for changes such as executive retirement and collateral loan extensions. This falls under the 'Major Shareholding Notification' category.
2023-06-02 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Korea Pharma Co., Ltd. covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.